Full Text View
Tabular View
No Study Results Posted
Related Studies
Vasoconstrictors as Alternatives to Albumin After LVP (Large-Volume Paracentesis) in Cirrhosis
This study has been completed.
Study NCT00108355   Information provided by Department of Veterans Affairs

First Received on April 14, 2005.   Last Updated on April 1, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Ascites
Cirrhosis
Additional conditions recognized in this trial
Fibrosis
Liver Cirrhosis
More general conditions related to this trial
Digestive System Diseases
Liver Diseases
Pathologic Processes
Interventions listed in this trial
albumin
octreotide plus midodrine
Additional drug interventions recognized in this trial
Midodrine
Octreotide
Vasoconstrictor Agents
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Agonists
Adrenergic alpha-1 Receptor Agonists
Adrenergic alpha-Agonists
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Autonomic Agents
Cardiovascular Agents
Gastrointestinal Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sympathomimetics
Therapeutic Uses
Sponsors listed in this trial
Department of Veterans Affairs


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services